iBio, Inc.IBIONYSE
Loading
SG&A Expenses Over TimeStable
Percentile Rank80
3Y CAGR-12.3%
5Y CAGR-10.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-12.3%/yr
vs +11.4%/yr prior
5Y CAGR
-10.2%/yr
Consistent
Acceleration
-23.8pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$12.81M+19.9%
2025$10.69M-8.4%
2024$11.67M-38.6%
2023$19.02M+5.9%
2022$17.96M-17.9%
2021$21.89M+92.6%
2020$11.37M-7.8%
2019$12.33M+15.4%
2018$10.69M+1.3%
2017$10.55M-